| Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis S Moran, A Martínez-Cardús, S Sayols, E Musulén, C Balañá, ... The Lancet Oncology 17 (10), 1386-1395, 2016 | 434 | 2016 |
| Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study A Vitale, RR Morales, G Zanus, F Farinati, P Burra, P Angeli, AC Frigo, ... The lancet oncology 12 (7), 654-662, 2011 | 175 | 2011 |
| Neurosteroid biosynthetic pathways changes in prefrontal cortex in Alzheimer's disease S Luchetti, K Bossers, S Van de Bilt, V Agrapart, RR Morales, GV Frajese, ... Neurobiology of aging 32 (11), 1964-1976, 2011 | 123 | 2011 |
| A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list A Vitale, ML Volk, TM De Feo, P Burra, AC Frigo, RR Morales, L De Carlis, ... Journal of hepatology 60 (2), 290-297, 2014 | 100 | 2014 |
| Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002–2033: the ITA. LI. CA database A Vitale, G Svegliati-Baroni, A Ortolani, M Cucco, GV Dalla Riva, ... Gut 72 (1), 141-152, 2023 | 76 | 2023 |
| In-silico drug repurposing study predicts the combination of pirfenidone and melatonin as a promising candidate therapy to reduce SARS-CoV-2 infection progression and … L Artigas, M Coma, P Matos-Filipe, J Aguirre-Plans, J Farrés, R Valls, ... PLoS One 15 (10), e0240149, 2020 | 68 | 2020 |
| SERPINB3 is associated with TGF-β1 and cytoplasmic β-catenin expression in hepatocellular carcinomas with poor prognosis C Turato, A Vitale, S Fasolato, M Ruvoletto, L Terrin, S Quarta, ... British journal of cancer 110 (11), 2708-2715, 2014 | 67 | 2014 |
| Is resectable hepatocellular carcinoma a contraindication to liver transplantation? A novel decision model based on “number of patients needed to transplant” as measure of … A Vitale, A Cucchetti, GL Qiao, M Cescon, J Li, RR Morales, AC Frigo, ... Journal of hepatology 60 (6), 1165-1171, 2014 | 65 | 2014 |
| Use of N‐acetylcysteine during liver procurement: A prospective randomized controlled study F D'Amico, A Vitale, D Piovan, A Bertacco, R Ramirez Morales, ... Liver Transplantation 19 (2), 135-144, 2013 | 57 | 2013 |
| Sorafenib for the treatment of recurrent hepatocellular carcinoma after liver transplantation? A Vitale, P Boccagni, X Kertusha, G Zanus, F D'Amico, E Lodo, ... Transplantation proceedings 44 (7), 1989-1991, 2012 | 41 | 2012 |
| Sequencing of taxanes and new androgen-targeted therapies in metastatic castration-resistant prostate cancer: results of the international multicentre retrospective CATS database N Delanoy, AC Hardy-Bessard, E Efstathiou, S Le Moulec, U Basso, ... European urology oncology 1 (6), 467-475, 2018 | 35 | 2018 |
| Very early introduction of everolimus in de novo liver transplantation: results of a multicenter, prospective, randomized trial U Cillo, L Saracino, A Vitale, A Bertacco, M Salizzoni, F Lupo, M Colledan, ... Liver Transplantation 25 (2), 242-251, 2019 | 34 | 2019 |
| Liver Transplantation North Italy Transplant program (NITp) working group. A method for establishing allocation equity among patients with and without hepatocellular carcinoma … A Vitale, ML Volk, TM De Feo, P Burra, AC Frigo, R Ramirez Morales, ... J Hepatol 60 (2), 290-7, 2014 | 31 | 2014 |
| Italian Liver Cancer group. Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study A Vitale, RR Morales, G Zanus, F Farinati, P Burra, P Angeli, AC Frigo, ... Lancet Oncol 12 (7), 654-62, 2011 | 24 | 2011 |
| Donor-Model for End-Stage Liver Disease and donor-recipient matching in liver transplantation A Vitale, RR Morales, E Dalla Bona, M Scopelliti, G Zanus, D Neri, ... Transplantation proceedings 43 (4), 974-976, 2011 | 17 | 2011 |
| Sexual dimorphic evolution of metabolic programming in non-genetic non-alimentary mild metabolic syndrome model in mice depends on feed-back mechanisms integrity for pro … S Loizzo, S Vella, A Loizzo, A Fortuna, A Di Biase, S Salvati, GV Frajese, ... Peptides 31 (8), 1598-1605, 2010 | 17 | 2010 |
| Model for end‐stage liver disease‐sodium and survival benefit in liver transplantation A Vitale, A Bertacco, M Gambato, F D'Amico, RR Morales, AC Frigo, ... Transplant International 26 (2), 138-144, 2013 | 12 | 2013 |
| Molecular refinement of clinical staging in hepatocellular carcinoma patients evaluated for potentially curative therapies A Vitale, F Navaglia, R Ramírez Morales, AC Frigo, D Basso, F D'Amico, ... PloS one 6 (9), e23093, 2011 | 7 | 2011 |
| Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration resistant prostate cancer: The CATS international database N Delanoy, AC Hardy-Bessard, E Efstathiou, S Le Moulec, U Basso, ... European Journal of Cancer 125, 153-163, 2020 | 6 | 2020 |
| Potential impact of sorafenib on the survival benefit of liver transplantation for hepatocellular carcinoma A Vitale, G Lombardi, RR Morales, U Cillo Digestive and Liver Disease 44 (5), 361-362, 2012 | 6 | 2012 |
